Valuation PT Ikapharmindo Putramas Tbk

Stocks

End-of-day quote INDONESIA S.E. Other stock markets 2026-07-31			5-day change	1st Jan Change
187.00 ^IDR	+2.19%		+1.08%	-16.52%

07-28	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-24	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	340,302	411,058	377,364
Change	-	20.79%	-8.2%
Enterprise Value (EV) ¹	445,409	558,217	501,269
Change	-	25.33%	-10.2%
P/E	11.8x	82x	-13.1x
PBR	1.39x	1.67x	1.73x
PEG	3.87x	-1x	0x
Capitalization / Revenue	0.77x	1x	1.04x
EV / Revenue	1.01x	1.35x	1.38x
EV / EBITDA	10.6x	22x	-30.3x
EV / EBIT	14x	31.9x	-20.5x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	2.25	-	-
Rate of return	1.11%	-	-
EPS ²	17.08	2.977	-17.09
Distribution rate	13.2%	-	-
Net sales ¹	441,137	412,069	363,565
EBITDA ¹	41,844	25,345	-16,528
EBIT ¹	31,780	17,514	-24,485
Net income ¹	15,338	5,015	-28,785
Net Debt ¹	105,107	147,159	123,904
Reference price ²	202.00	244.00	224.00
Nbr of stocks (in thousands)	1,684,663	1,684,663	1,684,663
Announcement Date	4/29/24	3/26/25	3/16/26

¹IDR in Million²IDR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
PT IKAPHARMINDO PUTRAMAS TBK	-	-	-	-	17.45M
ELI LILLY AND COMPANY	35.03x	12.19x	25.61x	0.59%	1,024B
JOHNSON & JOHNSON	27.48x	6.29x	17.54x	2.1%	618B
ABBVIE INC.	32.57x	7.42x	15.35x	2.76%	443B
ROCHE HOLDING AG	19.7x	4.68x	11.59x	2.83%	349B
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	264B
NOVO NORDISK A/S	13.48x	5.05x	10.4x	3.71%	209B
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	208B
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	162B
PFIZER INC.	12.69x	3.11x	7.86x	6.88%	143B
Average	15.68x	6.16x	15.98x	2.89%	341.89B
Weighted average by Cap.	24.04x	7.68x	18.14x	2.14%